MendeliKABS

Manufacturing · Canada · 11-50 Employees

View Company Info for Free

Overview

Headquarters

4601 De Tonnancour St, Saint Hubert, Que...

Phone Number

+44 2080048190

Revenue

$5.3 Million

Industry

Manufacturing Pharmaceuticals
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About MendeliKABS

MendeliKABS specializes in the treatment of rare diseases, particularly hereditary tyrosinemia type 1, through their approved medication MDK-Nitisinone. The company focuses on providing affordable health solutions and integrates high-level expertise to manufacture drugs in compliance with international regulations. Their products aim to reduce the risk of severe health complications associated with orphan diseases. MendeliKABS is committed to making a difference in the lives of patients by offering accessible treatment options.Explore more
MendeliKABS's Social MediaPopular SearchesMendelikabs IncMendelikabsMendelikabs Europe LtdMendeliKABS pharmaceutiqueSIC Code 28,283NAICS Code 32,325Show more

MendeliKABS Org Chart

PhoneEmail
DT
Canada flag for contact location.

Directrice, Assurance Qualité

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is MendeliKABS your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to MendeliKABS

Compare insights from companies similar to MendeliKABS, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

MendeliKABS

$5.3M
11-50
Private
-
2013
DT
Dora TemesiDirectrice, Assurance Qualité
$60.4M
11-50
Private
-
2012
Karim Smaira, Founder & Chief Executive Officer at Genpharm Services
Karim SmairaFounder & CEO
$18.5M
51-200
Private
-
2010
RM
Rafik MaroufDirector, Medical Affairs
$18.1M
11-50
Private
-
-
JM
Janet McClungExecutive Area Manager
$5.2M
11-50
Private
-
-
RH
Rashbinder HashimiFounder & Researcher
<$5M
1-10
Public
-
2012
MF
Michael FrankChairman & CEO
<$5M
1-10
Private
$112M
2015
MB
Micheline BeauvaisPresident & CEO
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

MendeliKABS is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

MendeliKABS is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about MendeliKABS.

MendeliKABS Tech Stack

A closer look at the technologies used by MendeliKABS

Top Manufacturing Companies

Frequently Asked Questions Regarding MendeliKABS

What is MendeliKABS's official website?
MendeliKABS's official website is www.mendelikabs.com
What is MendeliKABS's Revenue?
MendeliKABS's revenue is $5.3 Million
What is MendeliKABS's SIC code?
MendeliKABS's SIC: 28,283
What is MendeliKABS's NAICS code?
MendeliKABS's NAICS: 32,325
How many employees does MendeliKABS have?
MendeliKABS has 11-50 employees
What industry does MendeliKABS belong to?
MendeliKABS is in the industry of: Manufacturing, Pharmaceuticals
What is MendeliKABS competition?
MendeliKABS top competitors include: Inversago Pharma, Genpharm Services, Bio-Herb Remedies, Medunik Canada
What technology does MendeliKABS use?
Some of the popular technologies that MendeliKABS uses are: WordPress.org, PHP, Google Universal Analytics, Google Font API
How do I contact MendeliKABS?
MendeliKABS contact info: Phone number: +44 2080048190 Website: www.mendelikabs.com
What does MendeliKABS do?

MendeliKABS specializes in the treatment of rare diseases, particularly hereditary tyrosinemia type 1, through their approved medication MDK-Nitisinone. The company focuses on providing affordable health solutions and integrates high-level expertise to manufacture drugs in compliance with international regulations. Their products aim to reduce the... risk of severe health complications associated with orphan diseases. MendeliKABS is committed to making a difference in the lives of patients by offering accessible treatment options.Read More

What are MendeliKABS social media links?
MendeliKABS Facebook page
Is MendeliKABS a public company?
MendeliKABS is private company therefore does not currently have an official ticker symbol
See more information about MendeliKABS

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.